These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22826359)

  • 1. Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials.
    Palacio S; Hart RG; Pearce LA; Benavente OR
    Stroke; 2012 Aug; 43(8):2157-62. PubMed ID: 22826359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.
    ; Benavente OR; Hart RG; McClure LA; Szychowski JM; Coffey CS; Pearce LA
    N Engl J Med; 2012 Aug; 367(9):817-25. PubMed ID: 22931315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events.
    Squizzato A; Bellesini M; Takeda A; Middeldorp S; Donadini MP
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD005158. PubMed ID: 29240976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental effect of clopidogrel on important outcomes in patients with cardiovascular disease: a meta-analysis of randomized trials.
    Helton TJ; Bavry AA; Kumbhani DJ; Duggal S; Roukoz H; Bhatt DL
    Am J Cardiovasc Drugs; 2007; 7(4):289-97. PubMed ID: 17696569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis.
    Greenhalgh J; Bagust A; Boland A; Martin Saborido C; Oyee J; Blundell M; Dundar Y; Dickson R; Proudlove C; Fisher M
    Health Technol Assess; 2011 Sep; 15(31):1-178. PubMed ID: 21888837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
    Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
    Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial.
    Valgimigli M; Campo G; Monti M; Vranckx P; Percoco G; Tumscitz C; Castriota F; Colombo F; Tebaldi M; Fucà G; Kubbajeh M; Cangiano E; Minarelli M; Scalone A; Cavazza C; Frangione A; Borghesi M; Marchesini J; Parrinello G; Ferrari R;
    Circulation; 2012 Apr; 125(16):2015-26. PubMed ID: 22438530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation.
    Main C; Palmer S; Griffin S; Jones L; Orton V; Sculpher M; Henderson R; Sudlow C; Hawkins N; Riemsma R
    Health Technol Assess; 2004 Oct; 8(40):iii-iv, xv-xvi, 1-141. PubMed ID: 15461878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of mortality in patients with lacunar stroke in the secondary prevention of small subcortical strokes trial.
    Sharma M; Pearce LA; Benavente OR; Anderson DC; Connolly SJ; Palacio S; Coffey CS; Hart RG
    Stroke; 2014 Oct; 45(10):2989-94. PubMed ID: 25158772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable.
    Connolly SJ; Eikelboom JW; Ng J; Hirsh J; Yusuf S; Pogue J; de Caterina R; Hohnloser S; Hart RG;
    Ann Intern Med; 2011 Nov; 155(9):579-86. PubMed ID: 22041946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
    Gouya G; Arrich J; Wolzt M; Huber K; Verheugt FW; Gurbel PA; Pirker-Kees A; Siller-Matula JM
    Stroke; 2014 Feb; 45(2):492-503. PubMed ID: 24368560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.
    Steinhubl SR; Berger PB; Mann JT; Fry ET; DeLago A; Wilmer C; Topol EJ;
    JAMA; 2002 Nov; 288(19):2411-20. PubMed ID: 12435254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Clopidogrel Therapy on Mortality and Cancer in Patients With Cardiovascular and Cerebrovascular Disease: A Patient-Level Meta-Analysis.
    Elmariah S; Doros G; Benavente OR; Bhatt DL; Connolly SJ; Yusuf S; Steinhubl SR; Liu Y; Hsieh WH; Yeh RW; Mauri L
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005795. PubMed ID: 29311290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of clopidogrel plus aspirin versus aspirin alone on the progression of native coronary artery disease after bypass surgery: analysis from the Clopidogrel After Surgery for Coronary Artery DiseasE (CASCADE) randomized trial.
    Une D; Al-Atassi T; Kulik A; Voisine P; Le May M; Ruel M
    Circulation; 2014 Sep; 130(11 Suppl 1):S12-8. PubMed ID: 25200049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of addition of clopidogrel to aspirin on subdural hematoma: meta-analysis of randomized clinical trials.
    Bakheet MF; Pearce LA; Hart RG
    Int J Stroke; 2015 Jun; 10(4):501-5. PubMed ID: 25472690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
    Berger PB; Bhatt DL; Fuster V; Steg PG; Fox KA; Shao M; Brennan DM; Hacke W; Montalescot G; Steinhubl SR; Topol EJ;
    Circulation; 2010 Jun; 121(23):2575-83. PubMed ID: 20516378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.
    Deo SV; Dunlay SM; Shah IK; Altarabsheh SE; Erwin PJ; Boilson BA; Park SJ; Joyce LD
    J Card Surg; 2013 Mar; 28(2):109-16. PubMed ID: 23488578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ASA failure: does the combination ASA/clopidogrel confer better long-term vascular protection?
    Côté R; Zhang Y; Hart RG; McClure LA; Anderson DC; Talbert RL; Benavente OR
    Neurology; 2014 Feb; 82(5):382-9. PubMed ID: 24384643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary artery stents.
    Mueller C; Roskamm H; Neumann FJ; Hunziker P; Marsch S; Perruchoud A; Buettner HJ
    J Am Coll Cardiol; 2003 Mar; 41(6):969-73. PubMed ID: 12651043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions.
    Shoamanesh A; Pearce LA; Bazan C; Catanese L; McClure LA; Sharma M; Marti-Fabregas J; Anderson DC; Kase CS; Hart RG; Benavente OR;
    Ann Neurol; 2017 Aug; 82(2):196-207. PubMed ID: 28681535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.